UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
379.09
-9.19 (-2.37%)
At close: Sep 11, 2026, 4:00 PM EDT
378.65
-0.44 (-0.12%)
After-hours: Sep 11, 2026, 7:59 PM EDT
UnitedHealth Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 352,307 | 352,229 | 308,810 | 290,827 | 257,157 | 226,233 |
Total Interest & Dividend Income | 4,530 | 4,317 | 5,202 | 4,089 | 2,030 | 2,324 |
Non-Insurance Activities Revenue | 53,865 | 53,380 | 50,226 | 42,583 | 37,424 | 34,437 |
Other Revenue | 39,824 | 38,038 | 36,040 | 34,123 | 27,551 | 24,603 |
| 450,526 | 447,964 | 400,278 | 371,622 | 324,162 | 287,597 | |
Revenue Growth | 6.55% | 11.91% | 7.71% | 14.64% | 12.71% | 11.84% |
Policy Benefits | 310,223 | 313,372 | 264,185 | 241,894 | 210,842 | 186,911 |
Depreciation & Amortization | 4,285 | 4,361 | 4,099 | 3,972 | 3,400 | 3,103 |
Selling, General & Administrative | 60,478 | 58,192 | 53,013 | 54,628 | 47,782 | 42,579 |
Non-Insurance Activities Expense | 51,444 | 50,655 | 46,694 | 38,770 | 33,703 | 31,034 |
Total Operating Expenses | 426,430 | 426,580 | 367,991 | 339,264 | 295,727 | 263,627 |
Operating Income | 24,096 | 21,384 | 32,287 | 32,358 | 28,435 | 23,970 |
Interest Expense | -3,894 | -4,002 | -3,906 | -3,246 | -2,092 | -1,660 |
EBT Excluding Unusual Items | 20,202 | 17,382 | 28,381 | 29,112 | 26,343 | 22,310 |
Merger & Restructuring Charges | -2,420 | -2,420 | - | - | - | - |
Gain (Loss) on Sale of Assets | -342 | -265 | -8,310 | - | - | - |
Pretax Income | 17,440 | 14,697 | 20,071 | 29,112 | 26,343 | 22,310 |
Income Tax Expense | 2,528 | 1,890 | 4,829 | 5,968 | 5,704 | 4,578 |
Earnings From Continuing Ops. | 14,912 | 12,807 | 15,242 | 23,144 | 20,639 | 17,732 |
Minority Interest in Earnings | -790 | -751 | -837 | -763 | -519 | -447 |
Net Income | 14,122 | 12,056 | 14,405 | 22,381 | 20,120 | 17,285 |
Net Income to Common | 14,122 | 12,056 | 14,405 | 22,381 | 20,120 | 17,285 |
Net Income Growth | -33.69% | -16.31% | -35.64% | 11.24% | 16.40% | 12.22% |
Shares Outstanding (Basic) | 906 | 908 | 921 | 928 | 937 | 943 |
Shares Outstanding (Diluted) | 908 | 911 | 929 | 938 | 950 | 956 |
Shares Change | -1.47% | -1.94% | -0.96% | -1.26% | -0.63% | -0.52% |
EPS (Basic) | 15.60 | 13.28 | 15.64 | 24.12 | 21.47 | 18.33 |
EPS (Diluted) | 15.53 | 13.23 | 15.51 | 23.86 | 21.18 | 18.08 |
EPS Growth | -32.80% | -14.70% | -35.00% | 12.65% | 17.15% | 12.79% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 23,617 | 16,075 | 20,705 | 25,682 | 23,404 | 19,889 |
Free Cash Flow Per Share | 26.01 | 17.64 | 22.29 | 27.38 | 24.64 | 20.80 |
Dividend Per Share | 8.950 | 8.730 | 8.180 | 7.290 | 6.400 | 5.600 |
Dividend Growth | 5.17% | 6.72% | 12.21% | 13.91% | 14.29% | 15.94% |
Operating Margin | 5.35% | 4.77% | 8.07% | 8.71% | 8.77% | 8.33% |
Profit Margin | 3.14% | 2.69% | 3.60% | 6.02% | 6.21% | 6.01% |
Free Cash Flow Margin | 5.24% | 3.59% | 5.17% | 6.91% | 7.22% | 6.92% |
EBITDA | 26,681 | 24,045 | 34,986 | 35,130 | 30,835 | 26,173 |
EBITDA Margin | 5.92% | 5.37% | 8.74% | 9.45% | 9.51% | 9.10% |
D&A For EBITDA | 2,585 | 2,661 | 2,699 | 2,772 | 2,400 | 2,203 |
EBIT | 24,096 | 21,384 | 32,287 | 32,358 | 28,435 | 23,970 |
EBIT Margin | 5.35% | 4.77% | 8.07% | 8.71% | 8.77% | 8.33% |
Effective Tax Rate | 14.49% | 12.86% | 24.06% | 20.50% | 21.65% | 20.52% |
Revenue as Reported | 450,129 | 447,567 | 400,278 | 371,622 | 324,162 | 287,597 |